G

Glenmark Life Sciences Ltd
NSE:GLS

Watchlist Manager
Glenmark Life Sciences Ltd
NSE:GLS
Watchlist
Price: 1 057.2 INR 2.9% Market Closed
Market Cap: 129.5B INR
Have any thoughts about
Glenmark Life Sciences Ltd?
Write Note

Glenmark Life Sciences Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glenmark Life Sciences Ltd
Long-Term Investments Peer Comparison

Comparables:
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
M
MANKIND

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
G
Glenmark Life Sciences Ltd
NSE:GLS
Long-Term Investments
â‚ą82.9m
CAGR 3-Years
-1%
CAGR 5-Years
155%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Long-Term Investments
â‚ą12.6B
CAGR 3-Years
29%
CAGR 5-Years
17%
CAGR 10-Years
12%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Long-Term Investments
â‚ą65.6B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
24%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Long-Term Investments
â‚ą9.7B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
46%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Long-Term Investments
â‚ą686.7m
CAGR 3-Years
-10%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Long-Term Investments
â‚ą3.2B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Glenmark Life Sciences Ltd's Long-Term Investments?
Long-Term Investments
82.9m INR

Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Long-Term Investments amounts to 82.9m INR.

What is Glenmark Life Sciences Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
155%

Over the last year, the Long-Term Investments growth was 0%. The average annual Long-Term Investments growth rates for Glenmark Life Sciences Ltd have been -1% over the past three years , 155% over the past five years .

Back to Top